Exploring the Therapeutic Potential of Bromelain: Applications, Benefits, and Mechanisms

Author:

Kansakar Urna1,Trimarco Valentina2,Manzi Maria V.3ORCID,Cervi Edoardo4,Mone Pasquale156,Santulli Gaetano137ORCID

Affiliation:

1. Department of Medicine, Division of Cardiology, Wilf Family Cardiovascular Research Institute, Fleischer Institute for Diabetes and Metabolism (FIDAM), Albert Einstein College of Medicine, New York, NY 10461, USA

2. Department of Neuroscience, Reproductive Sciences and Dentistry, Federico II University, 80131 Naples, Italy

3. Department of Advanced Biomedical Sciences, Federico II University Hospital, 80131 Naples, Italy

4. Vein Clinic, University of Brescia, 25100 Brescia, Italy

5. Department of Medicine and Health Sciences “Vincenzo Tiberio”, University of Molise, 86100 Campobasso, Italy

6. Casa di Cura “Montevergine”, 83013 Avellino, Italy

7. Department of Molecular Pharmacology, Einstein Institute for Aging Research, Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Einstein Institute for Neuroimmunology and Inflammation (INI), Albert Einstein College of Medicine, New York, NY 10461, USA

Abstract

Bromelain is a mixture of proteolytic enzymes primarily extracted from the fruit and stem of the pineapple plant (Ananas comosus). It has a long history of traditional medicinal use in various cultures, particularly in Central and South America, where pineapple is native. This systematic review will delve into the history, structure, chemical properties, and medical indications of bromelain. Bromelain was first isolated and described in the late 19th century by researchers in Europe, who identified its proteolytic properties. Since then, bromelain has gained recognition in both traditional and modern medicine for its potential therapeutic effects.

Funder

National Institutes of Health (NIH): National Heart, Lung, and Blood Institute

National Institute of Diabetes and Digestive and Kidney Diseases

National Center for Advancing Translational Sciences

American Heart Association

Diabetes Action Research and Education Foundation

Monique Weill-Caulier and Irma T. Hirschl Trusts

Publisher

MDPI AG

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3